MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in the early detection and personalized treatment of Monocytopenia, improving health outcomes and reducing infection risks.
Explore how genetic testing unveils Mosaic Variegated Aneuploidy Syndrome 2, its diagnosis, novel CEP57 variant discovery, and impact on family planning and treatments.
Explore how genetic testing and whole-exome sequencing illuminate moyamoya disease 5, aiding early diagnosis and personalized treatments for better outcomes.
Unravel MCAHS1's genetic complexities with insights into early detection, personalized care, and genetic counseling, fostering hope through advanced testing.
Explore how genetic testing aids in diagnosing Multiple Mitochondrial Dysfunctions Syndrome 2, guiding treatment, and assisting in family planning and research advancements.
Explore genetic testing for Myopia 21, an autosomal dominant disorder. Learn about early diagnosis, personalized treatment, and family planning options.
Explore high myopia, its link to cataracts and vitreoretinal degeneration, and how genetic testing offers insights into tailored prevention and treatment strategies.
Genetic testing uncovers myostatin-related muscle hypertrophy, aiding early diagnosis, personalized health management, and family planning for optimal outcomes.